Thu, 26 May 2022

Oncology Molecular Diagnostics Market Overview:

Molecular diagnosis is a method used to identify a disease at the molecular level, such as proteins, DNA, and RNA, in a tissue or fluid. Various tools are used to detect specific sequences of DNA or RNA that may or may not be associated with the disease such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions, which are used for diagnosis and prediction of various infectious diseases, cancer, and other genetic disorders.

Request For Sample Report:

The Asia-Pacific oncology molecular diagnostics market was valued at $381.84 million in 2018 and is estimated to reach $732 million by 2026 growing at a CAGR of 9% for the forecast period of 2019–2026. The market is segmented on the basis of application, end user, and country. By application, it is segmented into colorectal, lung, hematological, breast, and others.. By end-user, it is categorized into hospitals, reference laboratories, and others (research institutes and academic institutes).

Country wise, the Asia-Pacific oncology molecular diagnostics market is analyzed across Australia, Vietnam, the Philippines, Thailand, and rest of Asia-Pacific. Australia was the highest contributor with $91.26 million in 2018, and is estimated to reach $175.55 million by 2026, registering a CAGR of 9.0% during the forecast period. This is attributed to rise in incidences of cancer cases and surge in demand for faster diagnosis of cancer.

Purchase Inquiry:

Key Market Players

  • bioMérieux SA
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Danaher (Cepheid)
  • Diasorin SPA
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Sysmex Corporation

Customization Request:

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current Asia-Pacific oncology molecular diagnostics market trends and forecast estimations
  • in-depth oncology molecular diagnostics market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • The projections in this report are made by analyzing the current trends and future market potential from 2019 to 2026.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the oncology molecular diagnostics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook.

Tags: , , , ,

See Campaign:

Contact Information:

Contact Us:

David Correa

5933 NE Win Sivers Drive

205, Portland, OR 97220

United States

Toll Free: 1-800-792-5285

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975


Tags:Reportedtimes, Financial Content, PR-Wirein, iCN Internal Distribution, Research Newswire, English

More Dallas News

Access More

Sign up for The Dallas News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!